Publication

Byline

Location

Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 18 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-labe... और पढ़ें


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 18 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety... और पढ़ें


2022 Birth Rates Reveal Demographic Divide Across Europe

India, May 18 -- Recent data regarding demographic balance highlights a significant variation in per capita birth events across European nations during the 2022 calendar year. Turkey and Iceland Lead... और पढ़ें


Global Child Survival Gaps Widened in 2023

India, May 18 -- Recent data on child mortality rates for those younger than four reveals a stark contrast in health outcomes between the world's wealthiest and most vulnerable regions. While several ... और पढ़ें


Global Neonatal Mortality Data Reveals Sharp Regional Disparities

India, May 18 -- Global health data for 2022 reveals a stark divide in the survival rates of newborns across different continents during their first month of life. Crisis in High-Burden Nations Indi... और पढ़ें


Global Disparity in 2023 Male Infant Mortality Rates

India, May 18 -- Recent data from the World Development Indicators reveals a stark contrast in survival outcomes for male infants across the globe during 2023. Regions Facing Extreme Risk African na... और पढ़ें


Global Analysis Reveals Severe Disparities in Female Infant Survival

India, May 18 -- Global health data from 2023 highlights a vast gap in female infant mortality rates across different regions and economic landscapes. Severe Challenges in Specific Regions The highe... और पढ़ें


Global Infant Mortality Rates Drop Significantly Over Two Decades

India, May 18 -- Global efforts to improve neonatal health have resulted in a significant downward trend in infant mortality across the world since the turn of the century. Female Mortality Reduction... और पढ़ें


Global 2022 Data Highlights Sharp Disparities in Male Infant Survival

India, May 18 -- Recent United Nations Sustainable Development Goal statistics for 2022 expose a profound divide in survival prospects for male infants under one year old. The data underscores how geo... और पढ़ें


Global Data Reveals Stark Divide in Female Infant Mortality Rates

India, May 18 -- Global healthcare statistics from 2022 highlight a profound disparity in survival outcomes for female infants based on their geographical location. While many nations have leveraged a... और पढ़ें